BioCentury
ARTICLE | Company News

Celera Genomics Group, Syrrx, Merck deal

December 17, 2001 8:00 AM UTC

Syrrx will determine the 3-dimensional structures of CRA protein drug targets for use in CRA’s small molecule identification programs. ...